Cargando…

Species-based comparison of disease severity and risk factors for disseminated Candida infections in pediatric patients

BACKGROUND: Pediatric Candida infections are associated with worse clinical outcomes and increased costs. Yet, it is not definitively known if particular species are associated with more severe illness. Differential risk factor exposures among the species group may also exist. We aimed to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Hawkshead, John J, Van Dyke, Russell B, Hassig, Susan E, Webber, Larry S, Begue, Rodolfo E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846055/
https://www.ncbi.nlm.nih.gov/pubmed/27143942
http://dx.doi.org/10.2147/IDR.S102490
_version_ 1782429028516364288
author Hawkshead, John J
Van Dyke, Russell B
Hassig, Susan E
Webber, Larry S
Begue, Rodolfo E
author_facet Hawkshead, John J
Van Dyke, Russell B
Hassig, Susan E
Webber, Larry S
Begue, Rodolfo E
author_sort Hawkshead, John J
collection PubMed
description BACKGROUND: Pediatric Candida infections are associated with worse clinical outcomes and increased costs. Yet, it is not definitively known if particular species are associated with more severe illness. Differential risk factor exposures among the species group may also exist. We aimed to determine whether certain Candida species are more strongly associated with worse outcomes, and whether certain risk factors more strongly predispose patients to infection with certain species. METHODS: Microbiology lab records from patients seen from 2003 to 2010 at an urban children’s hospital were reviewed for invasive or disseminated Candida infections. Data on measures of disease severity/outcome and risk factors were abstracted and analyzed to determine differences associated with various Candida species. RESULTS: Exactly 106 cases of infection were analyzed. Non-albicans species were associated with a significantly longer length of stay postdiagnosis (P=0.03), as well as longer treatment (P=0.02). Candida albicans was associated with a higher number of antihypotensive medications required (P=0.03) and length of mechanical ventilation postdiagnosis (P=0.05). Candida tropicalis was associated with the highest mortality (45.5%). Hypotension, which was found to be significantly associated with concurrent infection, was significantly associated with increased risk of mortality (odds ratio =5.85, P=0.005). Initial choice of antifungal therapy was not associated with differences in eventual patient mortality. Multivariate logistic regression modeling revealed a trend toward C. albicans infection in patients receiving antineoplastic chemotherapy and non-albicans infection in patients with >96 hours mechanical ventilation. CONCLUSION: Interspecies differences may exist for Candida in terms of disease severity and risk factors. Underlying morbidity and the role of concurrent infections may play a key role in poor outcomes.
format Online
Article
Text
id pubmed-4846055
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-48460552016-05-03 Species-based comparison of disease severity and risk factors for disseminated Candida infections in pediatric patients Hawkshead, John J Van Dyke, Russell B Hassig, Susan E Webber, Larry S Begue, Rodolfo E Infect Drug Resist Original Research BACKGROUND: Pediatric Candida infections are associated with worse clinical outcomes and increased costs. Yet, it is not definitively known if particular species are associated with more severe illness. Differential risk factor exposures among the species group may also exist. We aimed to determine whether certain Candida species are more strongly associated with worse outcomes, and whether certain risk factors more strongly predispose patients to infection with certain species. METHODS: Microbiology lab records from patients seen from 2003 to 2010 at an urban children’s hospital were reviewed for invasive or disseminated Candida infections. Data on measures of disease severity/outcome and risk factors were abstracted and analyzed to determine differences associated with various Candida species. RESULTS: Exactly 106 cases of infection were analyzed. Non-albicans species were associated with a significantly longer length of stay postdiagnosis (P=0.03), as well as longer treatment (P=0.02). Candida albicans was associated with a higher number of antihypotensive medications required (P=0.03) and length of mechanical ventilation postdiagnosis (P=0.05). Candida tropicalis was associated with the highest mortality (45.5%). Hypotension, which was found to be significantly associated with concurrent infection, was significantly associated with increased risk of mortality (odds ratio =5.85, P=0.005). Initial choice of antifungal therapy was not associated with differences in eventual patient mortality. Multivariate logistic regression modeling revealed a trend toward C. albicans infection in patients receiving antineoplastic chemotherapy and non-albicans infection in patients with >96 hours mechanical ventilation. CONCLUSION: Interspecies differences may exist for Candida in terms of disease severity and risk factors. Underlying morbidity and the role of concurrent infections may play a key role in poor outcomes. Dove Medical Press 2016-04-18 /pmc/articles/PMC4846055/ /pubmed/27143942 http://dx.doi.org/10.2147/IDR.S102490 Text en © 2016 Hawkshead et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Hawkshead, John J
Van Dyke, Russell B
Hassig, Susan E
Webber, Larry S
Begue, Rodolfo E
Species-based comparison of disease severity and risk factors for disseminated Candida infections in pediatric patients
title Species-based comparison of disease severity and risk factors for disseminated Candida infections in pediatric patients
title_full Species-based comparison of disease severity and risk factors for disseminated Candida infections in pediatric patients
title_fullStr Species-based comparison of disease severity and risk factors for disseminated Candida infections in pediatric patients
title_full_unstemmed Species-based comparison of disease severity and risk factors for disseminated Candida infections in pediatric patients
title_short Species-based comparison of disease severity and risk factors for disseminated Candida infections in pediatric patients
title_sort species-based comparison of disease severity and risk factors for disseminated candida infections in pediatric patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846055/
https://www.ncbi.nlm.nih.gov/pubmed/27143942
http://dx.doi.org/10.2147/IDR.S102490
work_keys_str_mv AT hawksheadjohnj speciesbasedcomparisonofdiseaseseverityandriskfactorsfordisseminatedcandidainfectionsinpediatricpatients
AT vandykerussellb speciesbasedcomparisonofdiseaseseverityandriskfactorsfordisseminatedcandidainfectionsinpediatricpatients
AT hassigsusane speciesbasedcomparisonofdiseaseseverityandriskfactorsfordisseminatedcandidainfectionsinpediatricpatients
AT webberlarrys speciesbasedcomparisonofdiseaseseverityandriskfactorsfordisseminatedcandidainfectionsinpediatricpatients
AT beguerodolfoe speciesbasedcomparisonofdiseaseseverityandriskfactorsfordisseminatedcandidainfectionsinpediatricpatients